Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Prognostic relevance of epigenetic regulation of drug pharmacology and myeloid genes in pediatric AML

Naifah Alshameri, Francisco Marchi, Soheil Meshinchi, Xueyuan Cao, Jeffrey Rubnitz, Raul Ribeiro, Stanley Pounds, Jatinder Lamba

Blood (2025) 146 (Supplement 1): 1712.

https://doi.org/10.1182/blood-2025-1712

Published: 2025

Journal Articles

Platelet proteomic signatures reveal neurodegenerative and mitochondrial pathways associated with pain phenotypes in sickle cell disease

Keesha Powell-Roach, Ugochi Ogu, Anandi Krishnan, Xueyuan Cao, M. Dennis Leo, Eboni Lance, Daniel Johnson, David Kakhniashvili, Yenisel Cruz-Almeida, Margaret (Peggy) Wallace, Diana Wilkie, Steven Goodman

Blood (2025) 146 (Supplement 1): 2925.

https://doi.org/10.1182/blood-2025-2925

Published: 2025

Journal Articles

A TFPI missense variant provides protection against severe febrile neutropenia in pediatric Acute Myeloid Leukemia

Satyavardhan Rao Nittu, Richard Marrero, Xueyuan Cao, Huiyun Wu, Raul Ribeiro, Jeffrey Rubnitz, Stanley Pounds, Jatinder Lamba

Blood (2025) 146 (Supplement 1): 7028.

https://doi.org/10.1182/blood-2025-7028

Published: 2025

Journal Articles

Proteomics reveals COX7B as a prognostically relevant oxphos-linked protein in pediatric AML

Ryanne Mulligan, Ya Huang, Xueyuan Cao, Junmin Peng, Raul Ribeiro, Jeffrey Rubnitz, Stanley Pounds, Jatinder Lamba

Blood (2025) 146 (Supplement 1): 5277.

https://doi.org/10.1182/blood-2025-5277

Published: 2025

Journal Articles

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Francisco Marchi, Ann-Kathrin Schade, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Jeffery M Klco, Alan S Gamis, Rhonda E. Ries, Anders Kolb, Richard Aplenc, Todd A. Alonzo, Stanley Pounds, Soheil Meshinchi, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 103.

https://doi.org/10.1182/blood-2024-207665

Published: 2024

Journal Articles

Genome-Wide Association Study Identifies Variants Predictive of Febrile Neutropenia during Induction I in Newly Diagnosed Pediatric Acute Myeloid Leukemia Patients

Satyavardhan Rao Nittu, Richard J Marrero, Xueyuan Cao, Huiyun Wu, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley Pounds, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 6110.

https://doi.org/10.1182/blood-2024-208130

Published: 2024

Journal Articles

Genome-Wide Association Study of Metabolites in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia Identified Novel Metabolite Quantitative Trait Loci

Richard J Marrero, Xueyuan Cao, Huiyun Wu, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley Pounds, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 4327.

https://doi.org/10.1182/blood-2024-193819

Published: 2024

Journal Articles

The Methylome Atlas of Acute Leukemia Enables Novel Clinical Diagnostic Tool for AML

Francisco Marchi, Marieke Landwehr, Fernando Sckaff, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Alan S Gamis, E. Anders Kolb, Richard Aplenc, Stanley Pounds, Todd A. Alonzo, Soheil Meshinchi, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 121.

https://doi.org/10.1182/blood-2023-186894

Published: 2023

Journal Articles

Leveraging Custom CRISPR/Cas9 Screens to Identify AraC-Daunorubicin-Etoposide (ADE), Gemtuzumab Ozogamicin (GO), and Bortezomib Response Modulators Association with Clinical Outcomes in Pediatric AML

Nam Nguyen, Phani Krishna Parcha, Abderrahmane Tagmount, Bailey Gregory, Jeffrey E. Rubnitz, Raul C. Ribeiro, Xueyuan Cao, Todd A. Alonzo, Richard Aplenc, Alan S Gamis, Todd Cooper, E. Anders Kolb, Soheil Meshinchi, Stanley Pounds, Christopher Vulpe, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 1558.

https://doi.org/10.1182/blood-2023-178832

Published: 2023

Journal Articles

Intensification of Therapy and Pharmacogenetic Personalization Mitigate Racial Disparities in Pediatric Acute Myeloid Leukemia Outcomes

Jatinder K. Lamba, Richard J Marrero, Huiyun Wu, Xueyuan Cao, Phani Krishna Parcha, Seth E. Karol, Hiroto Inaba, Dennis John Kuo, Barbara Degar, Kenneth Matthew Heym, Jeffrey Taub, Norman J. Lacayo, Ching-Hon Pui, Raul C. Ribeiro, Stanley Pounds, Jeffrey E. Rubnitz

Blood (2023) 142 (Supplement 1): 386.

https://doi.org/10.1182/blood-2023-173617

Published: 2023

Journal Articles

Relapse-Enriched Gene Expression Signature of Prognostic Relevance in Pediatric Acute Myeloid Leukemia

Satyavardhan Rao Nittu, Francisco Marchi, Nam Nguyen, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Alan S Gamis, E. Anders Kolb, Richard Aplenc, Jeffery Klco, Stanley Pounds, Todd A. Alonzo, Soheil Meshinchi, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 2926.

https://doi.org/10.1182/blood-2023-189029

Published: 2023

Journal Articles

Serum Copeptin, Perceived Stress, and Pain in Patients Living with Sickle Cell Disease

Keesha L. Roach, Ugochi Olivia Ogu, Erielle V. Culp, Xueyuan Cao, Jacquelyn M. Hart, Yenisel Cruz-Almeida, Margaret R. Wallace, Diana J. Wilkie

Blood (2023) 142 (Supplement 1): 7333.

https://doi.org/10.1182/blood-2023-186855

Published: 2023

Journal Articles

CRISPR/Cas9 Screen Identifies CPX-351 and 7+3 Regimens Response Modulators with Distinct Sensitive and Resistant Profiles

Nam Nguyen, Phani Krishna Parcha, Abderrahmane Tagmount, Bailey Gregory, Xueyuan Cao, Stanley Pounds, Christopher Vulpe, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 1412.

https://doi.org/10.1182/blood-2023-174281

Published: 2023

Journal Articles

A DNA Methylation Signature Predicts Clinical Outcome in Pediatric AML Patients

Blood (2023) 142 (Supplement 1): 835.

https://doi.org/10.1182/blood-2023-186505

Published: 2023

Journal Articles

GWAS Identifies Variants Associated with Minimal Residual Disease after Induction I in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia

Richard J Marrero, Xueyuan Cao, Huiyun Wu, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley Pounds, Jatinder K. Lamba

Blood (2023) 142 (Supplement 1): 2967.

https://doi.org/10.1182/blood-2023-179946

Published: 2023

Journal Articles

Proteomic Analysis Identifies Epigenetic Modifiers and Potential Negative Regulators of Leukemogenesis KMD6A and SETDB1 to be Induced Post In Vivo Decitabine Exposure in Pediatric AML

Jatinder K. Lamba, Xueyuan Cao, Huiyun Wu, Hiroto Inaba, Raul C. Ribeiro, Junmin Peng, Tanja A. Gruber, Jeffrey E. Rubnitz, Stanley B. Pounds

Blood (2022) 140 (Supplement 1): 6086–6087.

https://doi.org/10.1182/blood-2022-166671

Published: 2022

Journal Articles

Integrated Gene Expression Analysis Identifies ETS2 Involved in Oncogene Induced Senescence to be Associated with Poor Outcome in Paediatric AML

Phani Krishna Parcha, Xueyuan Cao, Jeffrey E. Rubnitz, Raul C. Ribeiro, Stanley B. Pounds, Jatinder K. Lamba

Blood (2022) 140 (Supplement 1): 11781–11782.

https://doi.org/10.1182/blood-2022-163689

Published: 2022

Journal Articles

A Cibersortx Signature Predicts Outcome in Pediatric AML Patients

Francisco Marchi, Fernando Sckaff, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley B. Pounds, Jatinder K. Lamba

Blood (2022) 140 (Supplement 1): 3441–3442.

https://doi.org/10.1182/blood-2022-163366

Published: 2022

Journal Articles

Personalization of Induction Therapy for Pediatric AML to Ara-C+Dauno+ Etoposide (ADE) or Clofarabine+Ara-C According to a Polygenic Ara-C SNP Score- ACS10

Jatinder K. Lamba, Richard J Marrero, Abdelrahman H Elsayed, Xueyuan Cao, Huiyun Wu, Hiroto Inaba, Susana C. Raimondi, Ching-Hon Pui, Raul C. Ribeiro, Jeffrey E. Rubnitz, Stanley B. Pounds

Blood (2022) 140 (Supplement 1): 1039–1040.

https://doi.org/10.1182/blood-2022-159657

Published: 2022

Journal Articles

Genome-Wide CRISPR/Cas9 Screen Identifies AraC-Daunorubicin-Etoposide (ADE) Response Modulators Associated with Clinical Outcomes in Pediatric AML

Nam H.K. Nguyen, Abderrahmane Tagmount, Jeffrey E. Rubnitz, Raul C. Ribeiro, Xueyuan Cao, Stanley B. Pounds, Chris D. Vulpe, Jatinder K. Lamba

Blood (2022) 140 (Supplement 1): 5947–5948.

https://doi.org/10.1182/blood-2022-159322

Published: 2022

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Prognostic relevance of epigenetic regulation of drug pharmacology and myeloid genes in pediatric AML

Platelet proteomic signatures reveal neurodegenerative and mitochondrial pathways associated with pain phenotypes in sickle cell disease

A TFPI missense variant provides protection against severe febrile neutropenia in pediatric Acute Myeloid Leukemia

Proteomics reveals COX7B as a prognostically relevant oxphos-linked protein in pediatric AML

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Genome-Wide Association Study Identifies Variants Predictive of Febrile Neutropenia during Induction I in Newly Diagnosed Pediatric Acute Myeloid Leukemia Patients

Genome-Wide Association Study of Metabolites in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia Identified Novel Metabolite Quantitative Trait Loci

The Methylome Atlas of Acute Leukemia Enables Novel Clinical Diagnostic Tool for AML

Leveraging Custom CRISPR/Cas9 Screens to Identify AraC-Daunorubicin-Etoposide (ADE), Gemtuzumab Ozogamicin (GO), and Bortezomib Response Modulators Association with Clinical Outcomes in Pediatric AML

Intensification of Therapy and Pharmacogenetic Personalization Mitigate Racial Disparities in Pediatric Acute Myeloid Leukemia Outcomes

Relapse-Enriched Gene Expression Signature of Prognostic Relevance in Pediatric Acute Myeloid Leukemia

Serum Copeptin, Perceived Stress, and Pain in Patients Living with Sickle Cell Disease

CRISPR/Cas9 Screen Identifies CPX-351 and 7+3 Regimens Response Modulators with Distinct Sensitive and Resistant Profiles

A DNA Methylation Signature Predicts Clinical Outcome in Pediatric AML Patients

GWAS Identifies Variants Associated with Minimal Residual Disease after Induction I in Pediatric Patients with Newly Diagnosed Acute Myeloid Leukemia

Proteomic Analysis Identifies Epigenetic Modifiers and Potential Negative Regulators of Leukemogenesis KMD6A and SETDB1 to be Induced Post In Vivo Decitabine Exposure in Pediatric AML

Integrated Gene Expression Analysis Identifies ETS2 Involved in Oncogene Induced Senescence to be Associated with Poor Outcome in Paediatric AML

A Cibersortx Signature Predicts Outcome in Pediatric AML Patients

Personalization of Induction Therapy for Pediatric AML to Ara-C+Dauno+ Etoposide (ADE) or Clofarabine+Ara-C According to a Polygenic Ara-C SNP Score- ACS10

Genome-Wide CRISPR/Cas9 Screen Identifies AraC-Daunorubicin-Etoposide (ADE) Response Modulators Associated with Clinical Outcomes in Pediatric AML

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only